Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer

Fig. 1

Humanized Bispecific Antibody (mPEG × HER2) Rapidly Confers PEG-NPs Tumor Specificity for Multimodality Imaging in Breast Cancer anti-mPEG BsAbs (mPEG × markers) provide an easy, universal and one-step formulation for any naive PEG-NPs to accelerate the development of targeted PEG-NPs for multimodality imaging in the clinic

Back to article page